Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects

NCT00851773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Healthy

Interventions

DRUG: semaglutide
DRUG: semaglutide
DRUG: semaglutide
DRUG: semaglutide
DRUG: semaglutide
DRUG: placebo
DRUG: placebo
DRUG: placebo
DRUG: placebo
DRUG: placebo

Sponsor

Novo Nordisk A/S